NBIS
Nebius Group N.V.
There isn't enough reported data to score NBIS yet.
PHI
PLDT Inc.
PHI's fundamentals are strong: its operating margin rose 22 points to 42% and it turned 17% of its revenue into free cash flow, though earnings per share fell 12%. Its PE isn't a useful guide right now because of how its recent earnings were reported.
NBIS Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Healthy | |
| Unavailable | |
| Healthy |
NBIS's profitability and balance sheet are currently healthy. There isn't enough data to rate its revenue and cash flow.
PHI Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Strong | |
| Under pressure |
PHI's profitability and cash flow are currently healthy, and its revenue is stable, but its balance sheet is under pressure.
NBIS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 68x | $22.45 | -83% |
| Fair | 114x | $37.67 | -71% |
| Current | 390x | $129 | — |
| Expensive | 666x | $220 | +71% |
Historical ranges are pointers, not guarantees.
NBIS's PE is 390x, but its earnings don't support one, so it isn't a reliable read right now.
PHI PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 7.8x | $16.13 | — |
| Cheap | 8.6x | $17.63 | +9.3% |
| Fair | 11x | $22.25 | +38% |
| Expensive | 22x | $46.34 | +187% |
Historical ranges are pointers, not guarantees.
PHI has the edge over NBIS in the historical PE scenario, which offers more potential upside but is not a forecast.
NBIS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses steady | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
NBIS has the edge over PHI on the outlook, with more favorable earnings and revenue expectations.
PHI Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Decline | |
| Stable | |
| Strongly weakening | |
| Limited | |
| High |
Analysts expect PHI's earnings and profitability to decline, with its revenue holding steady.
NBIS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q4 2025 | $0.33 | +$2.61 |
| Q4 2024 | -$2.28 | -456% |
| Q4 2023 | $0.64 | -36% |
| Q4 2022 | $1.00 | +$1.49 |
| Q4 2021 | -$0.49 | -156% |
| Q4 2020 | $0.87 | +89% |
| Q4 2019 | $0.46 | -73% |
| Q4 2018 | $1.71 | +434% |
NBIS has returned to profit: it earned $0.33 per share over the past year, after losing money the year before.
PHI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $2.06 | -12% |
| Q1 2026 | $2.17 | -5.2% |
| Q4 2025 | $2.18 | -7.2% |
| Q3 2025 | $2.13 | +9.2% |
| Q2 2025 | $2.33 | +21% |
| Q1 2025 | $2.29 | +15% |
| Q4 2024 | $2.35 | +21% |
| Q3 2024 | $1.95 | +144% |
PHI has the edge over NBIS in the latest year-over-year earnings comparison.
NBIS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2023 | $9.7B | +53% |
| Q4 2022 | $6.3B | +46% |
| Q4 2021 | $4.3B | +63% |
| Q4 2020 | $2.6B | +24% |
| Q4 2019 | $2.1B | +37% |
| Q4 2018 | $1.5B | +36% |
| Q4 2017 | $1.1B | +24% |
| Q4 2016 | $917M | +27% |
NBIS's revenue is growing: $530M last quarter, down 80% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q4 2025 | -115% | -112 points |
| Q4 2023 | 3.6% | -11 points |
| Q4 2022 | 2.5% | -14 points |
| Q4 2021 | -3.7% | -18 points |
| Q4 2020 | 7.4% | -9.5 points |
| Q4 2019 | 14% | -2 points |
| Q4 2018 | 16% | -14 points |
| Q4 2017 | 14% | -19 points |
NBIS's operating margin was −115% last quarter, down 123 points from the same quarter a year ago, near the bottom of its range since 2011.
PHI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $873.8M | +2.2% |
| Q1 2026 | $889.9M | +2.2% |
| Q4 2025 | $864.8M | -1.7% |
| Q3 2025 | $845.7M | +0.7% |
| Q2 2025 | $855M | +1.8% |
| Q1 2025 | $870.4M | +1.9% |
| Q4 2024 | $880.1M | +2.4% |
| Q3 2024 | $840.2M | +2% |
PHI has the edge over NBIS in the latest year-over-year revenue comparison.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 52% | +25 points |
| Q1 2026 | 50% | +22 points |
| Q4 2025 | 14% | -4.1 points |
| Q3 2025 | 52% | +46 points |
| Q2 2025 | 27% | +3.8 points |
| Q1 2025 | 28% | -0.6 points |
| Q4 2024 | 18% | -25 points |
| Q3 2024 | 5.8% | -46 points |
PHI's operating margin was 52% last quarter, up 24 points from the same quarter a year ago.
NBIS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2025 | -$3.7B | -$3.1B |
| Q4 2024 | -$562.1M | -$316.2M |
| Q4 2023 | -$245.9M | -$138.9M |
| Q4 2022 | -$107M | +$319.7M |
| Q4 2021 | -$426.7M | -539% |
| Q4 2020 | $97.3M | -66% |
| Q4 2019 | $287.9M | +$289.2M |
| Q4 2018 | -$1.3M | -101% |
NBIS has burned cash in six of the last eight quarters: −$4.6B over the past year, against −$43M the year before.
PHI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $183.9M | +176% |
| Q1 2026 | $115.6M | -13% |
| Q4 2025 | $134.2M | +$228.6M |
| Q3 2025 | $173.9M | +88% |
| Q2 2025 | $66.5M | -51% |
| Q1 2025 | $132.3M | +68% |
| Q4 2024 | -$94.4M | -172% |
| Q3 2024 | $92.4M | -54% |
PHI generated $608M in free cash flow over the past year, about three times what it generated the year before.
NBIS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -12% | -33.3M shares |
| 1 year | -32% | -115M shares |
| 3 years | -26% | -86.9M shares |
NBIS has the edge over PHI on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2024 | $10M |
| Q4 2021 | $84.1M |
| Q4 2020 | $122.8M |
| Q4 2019 | $17.2M |
| Q4 2018 | $121.8M |
| Q4 2014 | $101.7M |
| Q4 2013 | $102.9M |
PHI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -428K shares |
| 1 year | -0.2% | -442K shares |
| 3 years | 0% | -5K shares |
| 5 years | -0.2% | -520K shares |
| Available history | -0.5% | -1M shares |
PHI has 216M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
PHI hasn't bought back shares in the past year.
NBIS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2023 | 0.7x | Very low |
| Q4 2022 | -0.7x | Net Cash |
NBIS's net debt is less than a year of its operating earnings (EBITDA).
PHI Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 3.2x | Elevated |
| Q1 2026 | 3.2x | Elevated |
| Q4 2025 | 3.7x | Elevated |
| Q3 2025 | 3.1x | Elevated |
| Q2 2025 | 3.0x | Moderate |
| Q1 2025 | 3.0x | Moderate |
| Q4 2024 | 3.1x | Elevated |
| Q3 2024 | 3.4x | Elevated |
PHI's net debt is about 3.2 years of its operating earnings (EBITDA), up from 3.0 years a year ago.
NBIS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.0 | Neutral |
| Stochastic | 8.3 | Oversold |
NBIS's weekly RSI is 38 (neutral) and its Stochastic is 8 (oversold).
PHI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.4 | Neutral |
| Stochastic | 24.6 | Neutral |
PHI's weekly RSI is 36 (neutral) and its Stochastic is 25 (neutral).
NBIS PE vs Communication Services Sector
| Metric | NBIS | Sector median | Relative |
|---|---|---|---|
| PE | 390x | 16x | 2,264% above |
| PE % | 62 | 24 | 38 pts above |
NBIS is trading at 390x earnings, a 2264% premium to the Communication Services sector's median of 16x, though its earnings don't support one.
PHI PE vs Communication Services Sector
| Metric | PHI | Sector median | Relative |
|---|---|---|---|
| PE | 7.8x | 16x | 53% below |
| PE % | 5 | 26 | 21 pts below |
PHI has the edge over NBIS on valuation relative to its sector.
NBIS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $179.7 | 28% below |
| 20 week MA | $199.9 | 36% below |
| 50 week MA | $163.5 | 21% below |
| 100 week MA | $110.0 | 17% above |
NBIS has stronger trend alignment. NBIS is above 1 of 4 weekly averages versus PHI above 0 of 5.
PHI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $18.0 | 10% below |
| 20 week MA | $18.6 | 13% below |
| 50 week MA | $20.0 | 20% below |
| 100 week MA | $21.0 | 23% below |
| 200 week MA | $22.4 | 28% below |
PHI is in a downtrend: it's below all five of its weekly moving averages, and 28% below its 200-week average.
NBIS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2024 | $19.6 | $27.3 | +40% |
| 2025 | $27.3 | $87.6 | +221% |
| 2026 YTD | $87.6 | $128.6 | +47% |
NBIS has the edge over PHI on returns for 2026, with the stronger performance.
PHI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $19.8 | $28.0 | +41% |
| 2021 | $28.0 | $37.0 | +32% |
| 2022 | $37.0 | $22.7 | -39% |
| 2023 | $22.7 | $23.4 | +3.4% |
| 2024 | $23.4 | $22.1 | -5.8% |
| 2025 | $22.1 | $21.7 | -1.9% |
| 2026 YTD | $21.7 | $16.1 | -26% |
PHI has finished lower in three of the last six years. It's down 26% so far in 2026.